rTMS&MCITranscranial Magnetic Stimulation and Cognitive Stimulation for Mild Cognitive Impairment

This study focuses on Mild Cognitive Impairment (MCI), a condition that lies between normal aging and the early stages of neurodegenerative diseases. With an estimated 24.3 million people worldwide affected by neurocognitive disorders, it's crucial to explore effective treatments. The study combines Cognitive Stimulation (CS), a set of techniques to enhance cognitive abilities, with Transcranial Magnetic Stimulation (rTMS), a safe method that alters brain activity using electromagnetic fields. Previous evidence suggests that these two techniques together can improve MCI levels and cognitive functions. The goal is to gain a deeper understanding of their combined therapeutic potential for MCI. Participants in this study will undergo both CS and rTMS treatments. The effectiveness of these treatments will be measured using the Attention and Memory Neuropsychological Battery (NEUROPSI), Mini Mental State Examination (MMSE), and Montreal Cognitive Assessment (MoCA). These tests evaluate the level of cognitive impairment and seek to identify the presence of Mild Cognitive Impairment. The study aims to observe if the combination of CS and rTMS can lead to improvements in these test results, indicating a potential benefit for individuals with MCI.